ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.1562T>C (p.Ile521Thr)

dbSNP: rs727504328
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154423 SCV000204091 uncertain significance not specified 2016-09-01 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Pathogenic. The p.Ile521Thr variant in MYH7 has been identified by our laboratory in 1 Caucasian individual with HCM and 1 Caucasian individual with features of ARVC. It was absent from l arge population studies. Isoleucine (Ile) at position 521 is highly conserved in mammals and across evolutionarily distant species and the change to threonine ( Thr) was predicted to be pathogenic using a computational tool clinically valida ted by our laboratory. This tool's pathogenic prediction is estimated to be corr ect 94% of the time (Jordan 2011). In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Ile521Thr variant is unce rtain.
Invitae RCV000690654 SCV000818352 uncertain significance Hypertrophic cardiomyopathy 2022-11-09 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function. ClinVar contains an entry for this variant (Variation ID: 177795). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy and in an individual referred for genetic testing for this condition (PMID: 25611685, 27532257). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 521 of the MYH7 protein (p.Ile521Thr).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.